Seer Inc
NASDAQ:SEER

Watchlist Manager
Seer Inc Logo
Seer Inc
NASDAQ:SEER
Watchlist
Price: 1.82 USD -0.55% Market Closed
Market Cap: 101.5m USD

Seer Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Seer Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Seer Inc
NASDAQ:SEER
Cash from Operating Activities
-$46.1m
CAGR 3-Years
0%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Operating Activities
$7.7B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
12%
Danaher Corp
NYSE:DHR
Cash from Operating Activities
$6.3B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
5%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Operating Activities
$996.4m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Cash from Operating Activities
$1.5B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
1%
IQVIA Holdings Inc
NYSE:IQV
Cash from Operating Activities
$2.8B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
18%
No Stocks Found

Seer Inc
Glance View

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 118 full-time employees. The company went IPO on 2020-12-04. The firm enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The firm's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

SEER Intrinsic Value
3.67 USD
Undervaluation 50%
Intrinsic Value
Price

See Also

What is Seer Inc's Cash from Operating Activities?
Cash from Operating Activities
-46.1m USD

Based on the financial report for Dec 31, 2024, Seer Inc's Cash from Operating Activities amounts to -46.1m USD.

What is Seer Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-29%

Over the last year, the Cash from Operating Activities growth was 22%.

Back to Top